Vivo Capital
Future of Healthcare Innovation. Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, and Beijing, China. At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.
START PRE-ICO
01.10.18
FINISH PRE-ICO
15.10.18
START ICO
16.10.18
FINISH ICO
31.12.18
I've invested at Vivo Capital and feel scam here now

If you suspect fraud, it is better to bring it to the attention of the law enforcement authorities. With ICO frauds, every day counts because fraudsters can sweep up the evidence.

Feel free to contact us:
We will help you to find the data about fraud (rate $ 30 per hour). In the future, you can submit this report and the case to any competent lawyer. An example of a research report is available here.

Consult us free of charge about collecting debts from an ICO project bubnov@forensictokenlab.com or via telegram @ICO_Forensic_NOW
We also collect facts about the withdrawal of crypto active assets from the project. If you have any information available about a cryptocurrency, please, send it to us for analysis.

ICO
Date Pre-iCO
01.10.18 / 15.10.18
Date iCO
16.10.18 / 31.12.18
Project symbol
VCT
ICO token price
0.000020 ETH
Soft cap
120 000 000 USD
Hard cap
280 000 000 USD
Category
Investment
Health
Accepting
ETH
SCROLL
THE STRIP

Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, and Beijing, China. At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

TEAM
Lawrence Wang
Managing Director
Michael Chang
Managing Director
Jack Bech Nielsen
Managing Director
Gaurav Aggarwal
Managing Director
Frank Kung
Managing Partner
Albert Cha
Managing Partner
Shan Fu
Managing Partner
Chen Yu
Managing Partner
Derek Yang
Finance Director
Peiyi Zhao
Head of Legal
Albert Chang
Managing Partner
Edgar G. Engleman
Managing Partner
Mahendra G. Shah
Managing Director
Hwachie Lee
Managing Director
Jo Shen
Venture Partner
Yuh-geng Tsay
Venture Partner
Tracy Wu
General Director
Joseph Siletto
Managing Director
Daisy Xu
General Director
ADVISORS
Nathan Dau
Associate
Eric Trac
Associate
Tiantian Zhu
Analyst
Ethan Zhao
Associate
Tierney Y. Li
Analyst
Andrew D. Goldberg
Principal
Vinayak Nikam
Associate
Adrianne Chang
Consultant
Dan Dan Dong
Principal
Qi Zhu
Principal
Nina Feng
Principal
Kevin Dai
Principal
David Liu
Principal
Daniel Qin
Associate
Lingfei Zhao
Analyst
Sue Shao
Associate
Yixuan Li
Analyst
Waika Cheng
Analyst
Aaron Royston
Senior Associate
Ronghuan Lin
Advisor
I've invested at Vivo Capital and feel scam here now

If you suspect fraud, it is better to bring it to the attention of the law enforcement authorities. With ICO frauds, every day counts because fraudsters can sweep up the evidence.

Feel free to contact us:
We will help you to find the data about fraud (rate $ 30 per hour). In the future, you can submit this report and the case to any competent lawyer. An example of a research report is available here.

Consult us free of charge about collecting debts from an ICO project bubnov@forensictokenlab.com or via telegram @ICO_Forensic_NOW
We also collect facts about the withdrawal of crypto active assets from the project. If you have any information available about a cryptocurrency, please, send it to us for analysis.